Articles On CogState (ASX:CGS)

It has been a disappointing year for the CogState Limited (ASX: CGS) share price. Since the start of 2022, the neuroscience technology company’s shares have tumbled 43% to $1.45. Is the CogState share price in the buy zone? One leading b...

The All Ordinaries Index (ASX: XAO) is in the green today, lifting 0.72%, but these shares are defying its gains. They’re each trading lower on the back of their companies’ latest earnings being released. Let’s take a look at how thes...

    Image source: © Terovesalainen | Megapixl.com Image description: Person with mental stress seeking professional help   Highlights Several countries around the globe observe May as the month of Mental Health Awareness Globally...

The healthcare sector is Australia’s biggest employer, employing 1 in 7 Aussies or roughly two million people. Treasurer Josh Frydenberg announced last night that Australia’s health budget will top $132bn in 2022-23, up from $62bn a decade...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

At the time of writing, the ASX 200 Health Index (XHJ) is down by 1.10%, while the benchmark ASX 200 has fallen by 2.15%. It’s all about earnings today for ASX health stocks. Here’s a highlight of where they stand in the first half.   Round...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. During his Australian Open quar...

Key points The CogState share price fell as low as $1.84 today — 20% down on yesterday’s close The neuroscience technology company released a quarterly update today Clinical sale contracts have increased by 141%, hitting a new record T...

Wall Street loses early gains US stocks sailed in positive territory throughout the day before fading away in the last hour of trading. All three major benchmarks ended the day deep in the red – the S&P 500 by 1.1%, the Dow by 0.89%, an...

The CogState Ltd (ASX: CGS) share price is moving with gusto today following the release of its quarterly cash flow statement. In afternoon trade, shares in the neuroscience technology company are fetching $2.40, up 9.59%. Here’s what th...

ASX shares on the smaller end of town can sometimes feel like a double-edged sword. Their size and growth ambitions can, at times, deliver explosive returns. On the flip side, many small caps are fraught with execution risk and often strug...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

The ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index which climbed by 0.40% Biopharmaceutical company Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with f...

Leading the health stocks today is Nanosonics (ASX:NAN)  up 19.69% after flagging FY21 revenues of $103.1 million, with strong momentum in H2 where revenues came in at $60 million – up 39% from H1. The company installed 3,030 units of its a...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

The Cogstate Limited (ASX: CGS) share price is flying 4.53% high in trade today. Shares in the biotech company have received a boost after releasing a business update earlier today. Here’s what the company announced and why investors are j...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week Healthcare fi...

Wall Street mixed, oil prices volatile The US markets returned from the long weekend Independence Day holiday, and posted mixed results. The Dow Jones fell by 0.60%, S&P 500 was down 0.20%, but the Nasdaq rose by 0.17%. The Pentagon has...

Over the past month, a number of US FDA approvals have moved the share prices of global pharma stocks, including those traded here on the ASX. The biggest FDA announcement during the month came out of US-based Biogen, which received a contr...

Shares in Actinogen Medical Ltd (ASX: ACW) soared today after the company released news on the upcoming study of its drug designed to treat Alzheimer’s disease. At market close, the Actinogen share price was trading at 16 cents – 19.23% hi...

Recent advances in our still-shallow understanding of the human brain have led to a renewed interest in companies that focus on neuroscience. The most famous neuroscience startup, Elon Musk’s Neuralink, is probably the first company that co...

Ask a Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In Part 2 of this edition, Anacacia Capital founder and managing director Jeremy Samuel explains how to manage ris...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

ShareCafeAlzheimer’s Decision Sends Positive Message to Aussie Biotechs The US Food and Drug Administration’s landmark but controversial approval of a new treatment for Alzheimer’s disease suggests a sea change in the regulator’s attitude t...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

The CogState Limited (ASX: CGS) share price soared over 50% today after revealing some positive Japanese news. Cogstate is a neuroscience technology company that aims to optimise brain health assessments to advance the development of new me...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Investors in Melbourne-based digital cognitive assessment technology company Cogstate (ASX: CGS) received a serious dopamine hit today, after the company's partners received accelerated approval overnight for the Alzheimer's drug aducanumab...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.15% to 7,270.7 points. Four ASX shares that are not letting that hold them back today are...

Summary Dateline Resources has reported the second phase of ore sorting results for the Gold Links Gold Mine. Mad Paws has added 10K new customers from March to May. Aeris Resources’ share price has marked a new 52-week high of AU$0.2...

Cogstate (ASX:CGS) has become the latest ASX health stock to gain from an FDA green light even though it is only indirectly involved – right now. Overnight the US regulator approved the first Alzheimer’s therapy since 2003 and the first dru...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The Cogstate Limited (ASX: CGS) share price is rocketing higher on Tuesday morning. At the time of writing, the neuroscience technology company’s shares are up 73% to $1.60. Why is the Cogstate share price rocketing higher? Investors have...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week It has been...

The ASX quarterly earnings season is in full full swing. With so many releases every day, it’s easy for investors to miss what’s been happening, let alone identify winners from the losers. Stockhead has summarised a list of 8 small caps tha...

The CogState Limited (ASX: CGS) share price is currently rising as the company announced a business update to the market. Shares in the small cap healthcare company are currently rising by 5.82%. This takes the Cogstate share price to $1.0...

CogState Limited (ASX: CGS) shares performed well today after the company released its second quarterly report for FY21. At the market’s close, the CogState share price was trading 8.3% higher at $1.105.  What drove the CogState share pric...

Summary Medibio Limited disclosed that its sleep staging software, MEBsleep, has obtained CE Mark approval. With the CE Mark, the health technology player can accelerate MEBsleep commercialisation activities in the EEC. The Company is...

The Cogstate Limited (ASX: CGS) share price has been fluctuating today after the company released a business update to the ASX. Earlier today the Cogstate share price was trading 2.33% higher but has now dipped into the red and is down by...

Summary In 2020, the stock market stayed highly volatile due to the negative impact of the coronavirus pandemic.  However, the healthcare sector remained relatively stable and managed to give good returns to the investors. CogState, P...

The CogState Limited (ASX: CGS) share price is going ballistic today, up 44% at the time of writing. This will come as more good news to longer-term shareholders, who’ve seen the share price rocket 207% since the closing bell on 31 Decembe...

ShareCafeHidden Gems Webinar Recap – VMS, CGS, MHC, DSK   Catch up on the full webinar with presentations from Venture Minerals (ASX: VMS), Cogstate Limited (ASX: CGS), Manhattan Corporation (ASX: MHC) and Dusk Group Limited (ASX:DSK). Hid...

ShareCafeCogstate Limited (ASX: CGS) – Hidden Gems Webinar Presentation   Presenter – Brad O’Connor – CEO & MD – Founded in 1999 and listed on the Australian Securities Exchange in 2004, Cogstate (ASX.CGS) is a world-class neuroscience...

The CogState Limited (ASX: CGS) share price has surged up 24.7% at the time of writing to $1.34 a share after closing at $1.09 yesterday and opening at $1.15 this morning. This move represents a continuation of the stellar year Cogstate sh...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down a sizeable 1.4% to 6,071.1 points. Four shares that have not let that hold th...

The CogState Limited (ASX: CGS) share price has been an exceptionally strong performer on Monday. At the time of writing, the neuroscience technology company’s shares are up a massive 36% to a 52-week high of $1.08. Why is the CogState sha...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Scott Powe...

The Cogstate Limited (ASX: CGS) share price ripped more than 78% higher in early trade after the company released its quarterly cash flow statement and business update. It has since been sold down and is currently trading 30.95% higher at...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The life s...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...